Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 6:00 AM ET

Date/Time Source News Release
05/12/2025 06:26 PM EDT Business Wire Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
05/12/2025 06:23 PM EDT Business Wire Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
05/12/2025 04:00 PM EDT Business Wire Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day
05/06/2025 04:35 PM EDT Business Wire Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
05/06/2025 08:30 AM EDT Business Wire Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
04/28/2025 04:31 PM EDT Business Wire Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
04/03/2025 04:01 PM EDT Business Wire Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
03/17/2025 04:01 PM EDT Business Wire Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
03/06/2025 04:05 PM EST Business Wire Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference
02/06/2025 08:05 AM EST Business Wire Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile
Page

Additional News

As of June 8, 2025 • 6:00 AM ET

Date/Time Source News Release
05/13/2025 04:36 AM EDT SeekingAlpha Sangamo Therapeutics prices $23M securities offering
05/13/2025 01:00 AM EDT SeekingAlpha Sangamo Therapeutics misses top-line and bottom-line estimates; reaffirms FY25 outlook
05/12/2025 09:06 PM EDT SeekingAlpha Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
05/12/2025 05:55 PM EDT Zacks Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates
05/12/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sangamo Therapeutics Inc.
05/11/2025 05:35 PM EDT SeekingAlpha Sangamo Therapeutics Q1 2025 Earnings Preview
05/11/2025 08:00 AM EDT SeekingAlpha Earnings week ahead: PLUG, CSCO, WMT, BABA, AMT, JD, TCEHY, and more
05/08/2025 09:15 AM EDT Zacks Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.